NIKKI Drug Patent Profile
✉ Email this page to a colleague
When do Nikki patents expire, and what generic alternatives are available?
Nikki is a drug marketed by Lupin Ltd and is included in one NDA.
The generic ingredient in NIKKI is drospirenone; ethinyl estradiol. There are eleven drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the drospirenone; ethinyl estradiol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nikki
A generic version of NIKKI was approved as drospirenone; ethinyl estradiol by DR REDDYS LABS SA on September 7th, 2010.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NIKKI?
- What are the global sales for NIKKI?
- What is Average Wholesale Price for NIKKI?
Summary for NIKKI
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 9 |
| Patent Applications: | 209 |
| Drug Prices: | Drug price information for NIKKI |
| Drug Sales Revenues: | Drug sales revenues for NIKKI |
| DailyMed Link: | NIKKI at DailyMed |
US Patents and Regulatory Information for NIKKI
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lupin Ltd | NIKKI | drospirenone; ethinyl estradiol | TABLET;ORAL | 201661-001 | May 27, 2014 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
